Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
PROK ProKidney
10.390+0.040+0.39%
Close
02/03 16:00 ET
10.3900.0000.00%
Post Mkt Price 02/03 16:00 ET
High
10.550
Open
10.060
Turnover
766.85K
Low
10.020
Pre Close
10.350
Volume
74.13K
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Repligen (NASDAQ:RGEN) & ProKidney (NASDAQ:PROK) Financial Comparison
ProKidney (NASDAQ:PROK – Get Rating) and Repligen (NASDAQ:RGEN – Get Rating) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength
ProKidney Shares Were Trading Higher After the Company Announced the Publication of the Trial Design and Early Data Analysis From REGEN-003 in the Journal of Blood Purification.
ProKidney shares were trading higher after the company announced the publication of the trial design and early data analysis from REGEN-003 in the Journal of Blood Purification.
Fly Intel: Pre-market Movers
Why Lightning EMotors Shares Are Trading Lower By 9%; Here Are 20 Stocks Moving Premarket
Gainers Broadwind, Inc. (NASDAQ:BWEN) rose 68.1% to $3.80 in pre-market trading after the company reported transformational two-year, $175 million wind tower order with global wind turbine manufacture
ProKidney's Stock Jumps 29%
Shares of ProKidney Corp. (PROK) rallied about 29% in premarket trading on Wednesday, the day after the company said preliminary data from a Phase 2 study found that the company's investigational rena
Top Premarket Gainers
07:48 AM EST, 01/11/2023 (MT Newswires) -- Broadwind (BWEN) shares soared 62% premarket Wednesday after saying late Tuesday it has secured approximately $175 million in new wind tower orders. Biora Th
World Wrestling Entertainment, Bed Bath & Beyond And Some Other Big Stocks Moving Higher In Wednesday's Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today's pre-market trading session.Bed Bath & Beyond Inc. (NASDAQ:BBBY) shares jumped 22.5% to $2.54 in pre-
Fly Intel: After-Hours Movers
ProKidney Publishes Trial Design for Trial of REACT for Diabetes Related to CKD
ProKidney Announces Publication Of Trial Design For Phase 2 Multicenter Clinical Trial Of REACT For Late Stage 4 Diabetes-Related Chronic Kidney Disease
ProKidney Announces Publication Of Trial Design For Phase 2 Multicenter Clinical Trial Of REACT For Late Stage 4 Diabetes-Related Chronic Kidney Disease
Company Overview
More
ProKidney Corp（formerly Social Capital Suvretta Holdings Corp. III） is an advanced biotechnology company founded by innovators. The company was founded on 2015, is a pioneer in the innovative treatment of chronic kidney disease (CKD) through cell therapy.
CEO： Dr. Timothy Bertram, PhD
Market： NASDAQ
Listing Date： 06/30/2021
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet